Tumor and Blood B Cell Abundance Outperforms Established ICB Response Prediction Signatures in Head and Neck Cancer

This dataset contains processed flow cytometry data and clinical information for deidentified patients from Cohort 11, as well as deconvoluted cell abundances and clinical data for deidentified patients from Cohort 10, associated with the study titled "Tumor and Blood B Cell Abundance Outperforms Established Immune Checkpoint Blockade Response Prediction Signatures in Head and Neck Cancer" published in Annals of Oncology (2024). DOI: https://doi.org/10.1016/j.annonc.2024.11.008.